White Pine Investment Company’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-385,947
Closed -$3.49M 59
2019
Q4
$3.49M Sell
385,947
-28,245
-7% -$229K 1.43% 31
2019
Q3
$2.98M Buy
414,192
+242,827
+142% +$1.74M 1.35% 32
2019
Q2
$1.36M Buy
171,365
+9,065
+6% +$107K 0.64% 39
2019
Q1
$2.04M Buy
162,300
+4,625
+3% +$73.2K 1.02% 35
2018
Q4
$3.15M Sell
157,675
-25
-0% -$578 1.68% 29
2018
Q3
$4.48M Sell
157,700
-1,210
-0.8% -$28.9K 2.15% 23
2018
Q2
$3.35M Sell
158,910
-6,110
-4% -$116K 1.73% 29
2018
Q1
$2.35M Sell
165,020
-120
-0.1% -$1.72K 1.15% 35
2017
Q4
$2.03M Buy
165,140
+65,890
+66% +$929K 1% 33
2017
Q3
$1.77M Buy
99,250
+1,830
+2% +$37.7K 0.94% 34
2017
Q2
$2.47M Sell
97,420
-50
-0.1% -$1.2K 1.32% 32
2017
Q1
$2.17M Buy
97,470
+750
+0.8% +$14.4K 1.17% 36
2016
Q4
$1.43M Buy
96,720
+64,750
+203% +$1.28M 0.77% 37
2016
Q3
$787K Buy
+31,970
New +$747K 0.46% 43

Other funds holding EVH

White Pine Investment Company's EVH Position: Q1 2020 in Review

White Pine Investment Company sold out of Evolent Health (EVH) in Q1 2020, closing a stake of 385,947 shares — an estimated $3.49M sold.

White Pine Investment Company first reported a position in EVH in Q3 2016 and held it in 14 quarters. The position peaked at $4.48M in Q3 2018. 154 funds tracked by Wall St. Rank hold EVH as of Q1 2020.

  • White Pine Investment Company reported no remaining Evolent Health position as of Q1 2020 after selling out during the quarter.
  • White Pine Investment Company sold 385,947 Evolent Health shares in Q1 2020, an estimated $3.49M.
  • White Pine Investment Company first reported a position in Evolent Health in Q3 2016 and held it in 14 quarters.
  • White Pine Investment Company's Evolent Health position peaked at $4.48M in Q3 2018.
  • 154 funds tracked by Wall St. Rank held Evolent Health as of Q1 2020.

Based on White Pine Investment Company's 13F filing for Q1 2020, filed 23 Apr 2020.